stockNASDAQ: REGN • 12 Months Updates
Regeneron Pharmaceuticals (REGN) 12 Months
Showing Closing Date Range from Oct 21, 2025 to Oct 21, 2026.
Regeneron discovers, invents, and commercializes innovative medicines for eye diseases, allergic conditions, cancer, and rare diseases.
Investor Relations:regeneron.com
Price & Performance Trajectory
Regeneron Pharmaceuticals Inc.NASDAQ: REGN
Latest Close
$805.67
12 Months Updates Trajectory
Showing Closing Date Range from Oct 21, 2025 to Oct 21, 2026.Loading trajectory chart...
Click metric scorecards below to toggle price, return %, range & volume curvesREGN session performance
✓ Latest Close USD
$805.67
Latest session close
+$226.33vs period start
Period Return % % GAIN
+39.07%
Net period trajectory
Cumulative ReturnNormalized
High / Low Range SPREAD
$859.34 / $572.75
Period range envelope
$286.59channel spread
Total Volume SHARES
214.78M
Period turnover
Avg: 855.7K/dLiquidity
Historical Session Ledger
Daily open, high, low, and close prices with volume and period returns.
Historical Quotes & Breakdown(251 dates)
| Date | Close (USD) | Return % | High | Low | Volume |
|---|---|---|---|---|---|
| Oct 21, 2026 | $805.67 | -0.22% | $813.86 | $800.24 | 578.4K |
| Oct 20, 2026 | $807.48 | +3.25% | $807.86 | $789.69 | 619.5K |
| Oct 19, 2026 | $782.04 | -1.10% | $800.00 | $780.83 | 487.5K |
| Oct 16, 2026 | $790.74 | -0.70% | $805.68 | $787.33 | 653.5K |
| Oct 15, 2026 | $796.34 | +2.31% | $809.49 | $792.79 | 798.8K |
| Oct 14, 2026 | $778.36 | +3.35% | $781.84 | $755.21 | 878.0K |
| Oct 13, 2026 | $753.12 | -1.27% | $765.60 | $743.57 | 629.5K |
| Oct 12, 2026 | $762.81 | +2.18% | $768.66 | $745.67 | 618.1K |
| Oct 09, 2026 | $746.54 | +0.94% | $751.27 | $733.70 | 465.3K |
| Oct 08, 2026 | $739.57 | -0.34% | $744.50 | $723.65 | 499.0K |
| Oct 07, 2026 | $742.12 | +0.46% | $753.66 | $734.18 | 625.6K |
| Oct 06, 2026 | $738.72 | +1.62% | $740.51 | $727.16 | 582.8K |
| Oct 05, 2026 | $726.47 | -1.19% | $736.42 | $722.02 | 691.0K |
| Oct 02, 2026 | $735.20 | +0.05% | $742.50 | $729.20 | 607.7K |
| Sep 30, 2026 | $758.27 | +1.03% | $763.72 | $742.94 | 872.4K |
Page 1 of 17